Clinical Trial Update: Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cisplatin and irinotecan in locally advanced or metastatic esophageal or gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Platinol (cisplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED